Product NDC: | 16590-370 |
Proprietary Name: | ACYCLOVIR |
Non Proprietary Name: | ACYCLOVIR |
Active Ingredient(s): | 400 mg/1 & nbsp; ACYCLOVIR |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 16590-370 |
Labeler Name: | Stat Rx USA |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074980 |
Marketing Category: | ANDA |
Start Marketing Date: | 19980930 |
Package NDC: | 16590-370-30 |
Package Description: | 30 TABLET in 1 BOTTLE (16590-370-30) |
NDC Code | 16590-370-30 |
Proprietary Name | ACYCLOVIR |
Package Description | 30 TABLET in 1 BOTTLE (16590-370-30) |
Product NDC | 16590-370 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ACYCLOVIR |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19980930 |
Marketing Category Name | ANDA |
Labeler Name | Stat Rx USA |
Substance Name | ACYCLOVIR |
Strength Number | 400 |
Strength Unit | mg/1 |
Pharmaceutical Classes | DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient] |